The company describes its activities as “HealthScience consultancy” – it provides a range of communications services to clients from across the sector, including big pharma and medium-sized pharma business, as well as a long tail of smaller clients
At A Glance
That said, the founders and management teams of the constituents of the Alantra Pharma Fast 50 share some common characteristics. They are passionate about the potential of their businesses to deliver lasting societal change, determined to innovate, and ambitious about what they can achieve, whether commercially or scientifically. They offer the industry – and the world – a brighter future.
Each of the top seven businesses in this year’s ranking have achieved compound annualised revenue growth of more than 50% over the past two years. And in each of the three distinct subsectors of the ranking – consulting, pharma outsourcing, and development, wholesale and supply (DWS) – at least three businesses
have delivered more than 40%
Eagle Genomics provides another example of what a tech-enabled business can achieve in the pharma sector. It applies its analysis tools to very large genomic and microbiomic datasets where the potential number of interactions in between of the components is almost infinite; company is able to unlock new insights for scientists and drug developers
Fast Growing Pharma Company
While the pharmaceutical industry might be regarded as the ultimate defensive sector – the need to preserve and enhance human health is, after all, an inexorable imperative – it is not immune to the ebb and flow of global market cycles.
Evermed is ranks the UK’s fastest-growing, privately-owned pharmaceutical businesses according to their revenue growth over the past two years (the businesses must have reported revenues of more than £1m in the first year of assessment to be included).
Founder, CEO of evermed
Therapeutic Areas of Focus
Neurology and Oncology
Morningside’s expertise lies in the research, development and licencing of new products. Based in Leicester, the business has been licensing and supplying pharmaceutical products
since 2001 and currently has over 100 product marketing authorisations. Its products span a range of therapeutic areas including cardiology, dermatology, endocrinology, gastroenterology, gynecology, immunology, neurology, oncology and rheumatology.